Deskripsi

CONSORT flow diagram for the randomized controlled trial of Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 in 330 adults with IBS, detailing participant screening, allocation to three arms, and study completion rates.

Figure 1

Flowchart

Source Paper

Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.

Nutrients (2020)

PMID: 32019158

DOI: 10.3390/nu12020363

Cite This Figure

![Figure 1: CONSORT flow diagram for the randomized controlled trial of Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 in 330 adults with IBS, detailing participant screening, allocation to three arms, and study completion rates.]()

> Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." *Nutrients*, 2020. PMID: [32019158](https://pubmed.ncbi.nlm.nih.gov/32019158/)

<figure>
  <img src="" alt="CONSORT flow diagram for the randomized controlled trial of Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 in 330 adults with IBS, detailing participant screening, allocation to three arms, and study completion rates." />
  <figcaption>Figure 1. CONSORT flow diagram for the randomized controlled trial of Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 in 330 adults with IBS, detailing participant screening, allocation to three arms, and study completion rates.<br>  Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32019158/">32019158</a></figcaption>
</figure>

Bukti Terkait

Lactobacillus acidophilus untuk Irritable Bowel Syndrome (IBS)

Peringkat B · 3 studi